<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C842A34F-18F7-454D-A259-FED802368496"><gtr:id>C842A34F-18F7-454D-A259-FED802368496</gtr:id><gtr:name>University of Leicester</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Leicester</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE1 7RH</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:department>Immunology Infection and Inflam Diseases</gtr:department><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C842A34F-18F7-454D-A259-FED802368496"><gtr:id>C842A34F-18F7-454D-A259-FED802368496</gtr:id><gtr:name>University of Leicester</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Leicester</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE1 7RH</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/EAC6D94B-F564-4561-8B3D-1C81E583E1B7"><gtr:id>EAC6D94B-F564-4561-8B3D-1C81E583E1B7</gtr:id><gtr:firstName>Wuding</gtr:firstName><gtr:surname>Zhou</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/893D66CD-2721-4DA1-BC08-7050127B4B3A"><gtr:id>893D66CD-2721-4DA1-BC08-7050127B4B3A</gtr:id><gtr:firstName>Steven</gtr:firstName><gtr:otherNames>H</gtr:otherNames><gtr:surname>Sacks</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/FB4046D3-FCA3-4BF4-90CA-1FA857B89F32"><gtr:id>FB4046D3-FCA3-4BF4-90CA-1FA857B89F32</gtr:id><gtr:firstName>Giovanna</gtr:firstName><gtr:surname>Lombardi</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0600892"><gtr:id>BFD52D3C-6161-4485-998B-627257500958</gtr:id><gtr:title>Targeting the complement system in transplantation</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0600892</gtr:grantReference><gtr:abstractText>Complement consists of a normal set of circulating proteins whose role in fighting infection is long established, but which is also now known to impede the acceptance of healthy foreign tissue such as a kidney transplant. Complement seems to work together with more sophisticated elements of the immune response called T lymphocytes, and we now believe that collaboration between complement and T cells is essential for graft rejection. It follows that blocking the alliance between complement and lymphocytes may hold a key to a new method of treatment, which could lead to more effective prevention of graft rejection and allow lower use of toxic drugs that are directed against T lymphocytes. However in order to plan effectively, we need better understanding of the cells that produce and secrete complement and how complement enhances the performance of these cells to stimulate T lymphocytes. From a shortlist of two cell types transferred with the donor kidney, we propose to examine the relative importance of these cells types in triggering graft rejection. We also have strategies for reducing the secretion of complement by these cell types, and wish to see if we can build this into a treatment strategy suitable for clinical therapy. More effective ways to prevent rejection crises would be expected to cut graft losses in the short and long term, and thus lead to a significant health and economic benefit associated with transplant success.</gtr:abstractText><gtr:technicalSummary>Our laboratory has been instrumental in defining the role of complement in renal transplant rejection, in particular the role of local production of C3 on the inflammatory and immune responses influencing short and long term transplant survival. Key publications in Nature Medicine and the NEJM describe our findings. In order to correctly target therapeutic regulators that form part of our translational programme, we need to precisely identify the cell types whose properties depend on this local production. Parenchymal tissue cells and migratory antigen presenting cells (APC) of donor origin are prime candidates, as both are known, from our work on isolated cells, to secrete C3 and stimulate the immune system in a complement dependent manner. However we need to establish the primacy of these cell types on a more physiological basis and determine whether cell-targeted inhibition of the complement system is relevant to the goal of inducing immune hyporesponsiveness for human therapy. To accomplish this we will work to the following set of objectives. (1) We will generate mouse chimeras which produce C3 in either parenchymal or passenger APCs. Transplantation of organs from these mice will tell us the extent to which the recipient antidonor T cell response is dependent on parenchymal or passenger cell synthesis of C3. (2) Functional studies on APCs from the chimeric mice will determine if their potency for T cell stimulation is dependent on endogenous or exogenous synthesis of C3. (3) We will build a therapeutic strategy for inactivating complement at the surface of parenchymal cells and/or APCs using a membrane targeted complement regulator in a mouse model. (4) We shall extend our findings to a human system based on either peripheral blood and myeloid APC, or renal parenchymal cells, and human T cells. Our aim will be to show if gene silencing, protein inactivation or receptor blockade of C3 reduces the human T cell response and favours the generation of inhibitory T cells. Further exploitation of human therapy would then require targeting the relevant cell type, with appropriate timing at the correct location.</gtr:technicalSummary><gtr:fund><gtr:end>2013-01-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2007-02-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1279746</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Faculty of Medicine</gtr:department><gtr:description>Complement and Coagulation interaction in hyperacute rejection</gtr:description><gtr:id>E6176483-A88C-46EC-8144-EBD728C0D5EB</gtr:id><gtr:impact>Presentation of findings at international complement and transplant meetings.

Potential new treatment strategy relevant to sentised transplant recipients.

New IP registered for the membrane targeted antithrombin (PTL004 and PTL006).</gtr:impact><gtr:outcomeId>GoXHW4wcbZQ-2</gtr:outcomeId><gtr:partnerContribution>It has exposed new interactions between thrombin and complement regulators induced by antibody bidning and has identified a new therapeutic strategy for prevention of rejection</gtr:partnerContribution><gtr:piContribution>Rat model of hyperacute rejection. Model for therapeutic intervention by treatement of the donor organ with membrane associated thrombin and complement regulators</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Leicester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Infection, Immunity and Inflammation</gtr:department><gtr:description>The role of the lactin pathway (MASP2) in ischemia reperfusion injury</gtr:description><gtr:id>0AF3BB25-1F09-4B94-9BC4-D5BF2901190B</gtr:id><gtr:impact>Presentation at International complement and transplant meetings

Publication in PNAS; second publication submitted

Collaboration with industry (OMEROS) on a new theraputic monoclonal antibody</gtr:impact><gtr:outcomeId>FH8wJG2veKP-1</gtr:outcomeId><gtr:partnerContribution>Revised my thinking on the complement pathway responsible for triggering complement activation during and after transplantation</gtr:partnerContribution><gtr:piContribution>Models for ischemia reperfusion injury in native and transplant organs using knockout mice.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>King's College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Requirement of complement C3 for transplant tolerance induction</gtr:description><gtr:id>39BA9C13-1187-46B5-A7D5-3EBC442CC4FD</gtr:id><gtr:impact>The initial results showing the requirement for C3 in tolerance to skin grafts was presented at an international meeting.</gtr:impact><gtr:outcomeId>E5078E54AA2-1</gtr:outcomeId><gtr:partnerContribution>Provided a Clinical Fellow with an interest in complement and transplantation. This has enabled a new scientific question to be addressed.</gtr:partnerContribution><gtr:piContribution>Led to the initial observation that C3 deficient mice were resistant to tolerance induction.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>King's College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Centre for Transplantation</gtr:department><gtr:description>Complement and Coagulation interaction in hyperacute rejection</gtr:description><gtr:id>72766AF9-254A-433A-AA20-75B0B0DB0763</gtr:id><gtr:impact>Presentation of findings at international complement and transplant meetings.

Potential new treatment strategy relevant to sentised transplant recipients.

New IP registered for the membrane targeted antithrombin (PTL004 and PTL006).</gtr:impact><gtr:outcomeId>GoXHW4wcbZQ-1</gtr:outcomeId><gtr:partnerContribution>It has exposed new interactions between thrombin and complement regulators induced by antibody bidning and has identified a new therapeutic strategy for prevention of rejection</gtr:partnerContribution><gtr:piContribution>Rat model of hyperacute rejection. Model for therapeutic intervention by treatement of the donor organ with membrane associated thrombin and complement regulators</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>BBC Radio 4 Interview</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:id>415F445D-9DB1-47AC-BC30-E7C62371925F</gtr:id><gtr:impact>Prof Steven Sacks describes his work on finding an easier way to get the body to accept a new organ on BBC Radio 4.

Publicity for the MRC Centre for Transplantation.</gtr:impact><gtr:outcomeId>D9085ACDB71</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>ISN Nexus 2016 Berlin</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>619D4F00-15DB-460B-8FD8-7900FB79E14B</gtr:id><gtr:impact>Invited speaker and session chair ISN Nexus Symposium Berlin to share results and provoke discussion.</gtr:impact><gtr:outcomeId>58c90df46fcd61.24299383</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Seminar - Sir William Dunn School of Pathology</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>5EEC0902-0BD9-4FDC-B253-7AD8B88DEAEF</gtr:id><gtr:impact>Interest and further discussions followed

Strengthened links in support of application for UKRMP Immunology Stem Cell Hub</gtr:impact><gtr:outcomeId>545b88d8231e42.40563279</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Kidney Patient's Association Open Day</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:id>B490DA9F-85F5-450F-A5AE-A2BADD80DF2A</gtr:id><gtr:impact>Laboratory visit and talk concerning ongoing research.

Articles in National KPA Newsletter</gtr:impact><gtr:outcomeId>1CCB9DD0CF2</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Session Organiser for BSI 2013</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>0B7C9FA3-D787-4065-95F9-6F330B63F7F5</gtr:id><gtr:impact>None as yet - Meeting occurring 2-5 December 2013</gtr:impact><gtr:outcomeId>Bi5LqS5quVC</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:url>http://www.bsicongress.com/</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BBC Radio 4 Interview</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:id>B2F646F5-EB38-4A84-B8C2-EB5722356DF6</gtr:id><gtr:impact>BBC Radio 4 invited Professor Steven Sacks to talk about a new technique that would extend the life of a kidney transplant significantly.

The story received media attention and was later supported by the successful application of an award to help with first in man clinical trials.</gtr:impact><gtr:outcomeId>tEEMXwZdhdu</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>1727417</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Developmental Clinical Study</gtr:description><gtr:end>2014-06-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>A7FA6C87-5144-4CFD-9D43-BA11DFFC5A5A</gtr:id><gtr:outcomeId>dMPWsdPbFUQ0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>10000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Public Engagement Grant</gtr:description><gtr:end>2010-10-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>6D57810D-48A8-4A45-BC54-BC78042C6E37</gtr:id><gtr:outcomeId>kTmDxWEoebF0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>40000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NIHR Senior Investigator award</gtr:description><gtr:end>2012-04-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>989C0D22-BE75-49F9-BFF8-2121D851650C</gtr:id><gtr:outcomeId>nbqVX6xSMhL</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2008-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>250000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Centre Grant (Directors Initiative)</gtr:description><gtr:end>2012-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>3F020F10-3F6B-4AC0-86EA-DA572AA1F951</gtr:id><gtr:outcomeId>P1BpHPqvEVm0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>600000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Project Grant</gtr:description><gtr:end>2011-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>DD2F5C7B-9A23-4C6A-93FF-C91E3BB3212D</gtr:id><gtr:outcomeId>DC3113112640</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>40000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>British Transplant Society Fellowship Award</gtr:description><gtr:end>2009-10-02</gtr:end><gtr:fundingOrg>British Transplantation Society (BTS)</gtr:fundingOrg><gtr:id>AEC026DC-9DD7-4EC2-B8B6-7175E9D04A00</gtr:id><gtr:outcomeId>FD3EB77D75B0</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector><gtr:start>2008-09-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Technology Strategy Board Assessor Briefing for Healthcare</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>C846E241-849E-436D-9F5B-329010ACC953</gtr:id><gtr:outcomeId>545ca1618df9e3.81311432</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs><gtr:productOutput><gtr:description>A membrane targeted anti-coagulant for intented use in donor kidneys transplanted into high risk (highly sensitised) recipients. Currently at proof-of-principle stage in rat model. Current funding - MRC Centre Grant Directors Initiative.</gtr:description><gtr:id>A55EC003-25AA-409C-BC66-512CE0EEA5E3</gtr:id><gtr:impact>Patent application registered.</gtr:impact><gtr:outcomeId>Ly2vea15K3U</gtr:outcomeId><gtr:stage>Refinement.  Non-clinical</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>Membrane targeted anti-thrombin PTL006</gtr:title><gtr:type>Therapeutic Intervention - Drug</gtr:type><gtr:yearDevCompleted>2010</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Cloning of complement receptor 2 and modification to develop a new imaging tool for detection of complement activation by external body imaging.</gtr:description><gtr:id>883EDFF4-6FD3-4315-8012-327EF64D1864</gtr:id><gtr:impact>Work in progress.</gtr:impact><gtr:outcomeId>07D09A60764</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Complement imaging technology</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>7037CC59-A3B3-47F6-BC51-EE229F5AF31C</gtr:id><gtr:title>Anaphylatoxins in organ transplantation.</gtr:title><gtr:parentPublicationTitle>Seminars in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ef586f0ee752b9a48fb0607626bbadf"><gtr:id>8ef586f0ee752b9a48fb0607626bbadf</gtr:id><gtr:otherNames>Li K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1044-5323</gtr:issn><gtr:outcomeId>doi_13110_013_04_013</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A512E436-B826-4863-B818-4EEAC98B5E02</gtr:id><gtr:title>Locally produced and activated complement as a mediator of alloreactive T cells.</gtr:title><gtr:parentPublicationTitle>Frontiers in bioscience (Scholar edition)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f5c880ba39733a8c5294d52b49ae5760"><gtr:id>f5c880ba39733a8c5294d52b49ae5760</gtr:id><gtr:otherNames>Lalli PN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1945-0516</gtr:issn><gtr:outcomeId>58E8F114C92</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8B52BDFD-65A4-4698-A8C9-1B5947505ECC</gtr:id><gtr:title>Donor specific transplant tolerance is dependent on complement receptors.</gtr:title><gtr:parentPublicationTitle>Transplant international : official journal of the European Society for Organ Transplantation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b45355c9a618881be06116dbdce75346"><gtr:id>b45355c9a618881be06116dbdce75346</gtr:id><gtr:otherNames>Bartel G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0934-0874</gtr:issn><gtr:outcomeId>doi_13110__tri_12006</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A426982F-DAA4-477C-8754-F1A746948964</gtr:id><gtr:title>Dendritic cell function in allostimulation is modulated by C5aR signaling.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/92e71281a7b654e3b4d9e3098f4ece2e"><gtr:id>92e71281a7b654e3b4d9e3098f4ece2e</gtr:id><gtr:otherNames>Peng Q</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>2FE0D73AC6A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6C2D2EB8-8CC5-4FD9-9E7F-01066CA354AE</gtr:id><gtr:title>Functional modulation of human monocytes derived DCs by anaphylatoxins C3a and C5a.</gtr:title><gtr:parentPublicationTitle>Immunobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ef586f0ee752b9a48fb0607626bbadf"><gtr:id>8ef586f0ee752b9a48fb0607626bbadf</gtr:id><gtr:otherNames>Li K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0171-2985</gtr:issn><gtr:outcomeId>pm_13110_20_21855168</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9862826E-EB02-4844-B536-C15A9582D58B</gtr:id><gtr:title>The innate immune system and transplantation.</gtr:title><gtr:parentPublicationTitle>Cold Spring Harbor perspectives in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f41571013db636d13570fa10eaf335ba"><gtr:id>f41571013db636d13570fa10eaf335ba</gtr:id><gtr:otherNames>Farrar CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2157-1422</gtr:issn><gtr:outcomeId>pm_13110_20_24086066</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D7C57731-F5FA-47A2-B02A-3D0357E5E977</gtr:id><gtr:title>Graft-derived complement as a mediator of transplant injury.</gtr:title><gtr:parentPublicationTitle>Current opinion in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7a4a3cd997f841d3d0f26f99aa36df9b"><gtr:id>7a4a3cd997f841d3d0f26f99aa36df9b</gtr:id><gtr:otherNames>Zhou W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0952-7915</gtr:issn><gtr:outcomeId>4637F531DBC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2969E3D3-E99A-463B-947D-8D9CD2DAE5FD</gtr:id><gtr:title>Local production and activation of complement up-regulates the allostimulatory function of dendritic cells through C3a-C3aR interaction.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/92e71281a7b654e3b4d9e3098f4ece2e"><gtr:id>92e71281a7b654e3b4d9e3098f4ece2e</gtr:id><gtr:otherNames>Peng Q</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>7FB1126139F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4B927195-FBEB-45D0-855B-E6EE2AD0F849</gtr:id><gtr:title>C3a and C5a promote renal ischemia-reperfusion injury.</gtr:title><gtr:parentPublicationTitle>Journal of the American Society of Nephrology : JASN</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/92e71281a7b654e3b4d9e3098f4ece2e"><gtr:id>92e71281a7b654e3b4d9e3098f4ece2e</gtr:id><gtr:otherNames>Peng Q</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1046-6673</gtr:issn><gtr:outcomeId>pm_13110_20_22797180</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>360524E7-5430-4575-B335-2AA88B1559AF</gtr:id><gtr:title>Expression of complement components, receptors and regulators by human dendritic cells.</gtr:title><gtr:parentPublicationTitle>Molecular immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ef586f0ee752b9a48fb0607626bbadf"><gtr:id>8ef586f0ee752b9a48fb0607626bbadf</gtr:id><gtr:otherNames>Li K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0161-5890</gtr:issn><gtr:outcomeId>BDAE33AC_EBDAE33AC_E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>488E4C80-913A-4B88-8695-785BC1F081A8</gtr:id><gtr:title>C1 esterase inhibitor reduces lower extremity ischemia/reperfusion injury and associated lung damage.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9fbde246de427536ea9e3f889d2a2937"><gtr:id>9fbde246de427536ea9e3f889d2a2937</gtr:id><gtr:otherNames>Duehrkop C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_13110_20_23991040</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3712D95A-9B2F-46A2-9407-FF5CA1F5B51A</gtr:id><gtr:title>Deficiency of C5aR prolongs renal allograft survival.</gtr:title><gtr:parentPublicationTitle>Journal of the American Society of Nephrology : JASN</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/99f6924f8765fc02490873fd4b290945"><gtr:id>99f6924f8765fc02490873fd4b290945</gtr:id><gtr:otherNames>Li Q</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1046-6673</gtr:issn><gtr:outcomeId>BABC86195A0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F503DC8C-B34D-4D4A-B4A7-A548908559D4</gtr:id><gtr:title>Complement in organ transplantation.</gtr:title><gtr:parentPublicationTitle>Current opinion in organ transplantation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a316adfc796e81a38c1044af9c04fdd4"><gtr:id>a316adfc796e81a38c1044af9c04fdd4</gtr:id><gtr:otherNames>Asgari E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1087-2418</gtr:issn><gtr:outcomeId>bSTZfwRyX74</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1B62F6C7-C51B-42C4-84D4-D3C10ADD9A95</gtr:id><gtr:title>Synthesis of complement protein C3 in the kidney is an important mediator of local tissue injury.</gtr:title><gtr:parentPublicationTitle>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5dba42c9a661e7f3a5d2c9d7fe2a96fe"><gtr:id>5dba42c9a661e7f3a5d2c9d7fe2a96fe</gtr:id><gtr:otherNames>Sheerin NS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0892-6638</gtr:issn><gtr:outcomeId>51362C66A6C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BA836C8C-F026-41B8-A9A6-135A1973A1C1</gtr:id><gtr:title>Complement fragments C3a and C5a: the salt and pepper of the immune response.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ff9ec214617661fdfb7e5229c6dcdcbf"><gtr:id>ff9ec214617661fdfb7e5229c6dcdcbf</gtr:id><gtr:otherNames>Sacks SH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>A185B14377A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E2121174-111C-4F1E-952B-551273116759</gtr:id><gtr:title>The role of complement in regulating the alloresponse.</gtr:title><gtr:parentPublicationTitle>Current opinion in organ transplantation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8c12df69d984c2e012769607eaadd6a4"><gtr:id>8c12df69d984c2e012769607eaadd6a4</gtr:id><gtr:otherNames>Sacks S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1087-2418</gtr:issn><gtr:outcomeId>1370FFEDE4B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AD1E76FE-D255-4AEB-B688-51FCD3FDB37A</gtr:id><gtr:title>Cyclic AMP plays a critical role in C3a-receptor-mediated regulation of dendritic cells in antigen uptake and T-cell stimulation.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ef586f0ee752b9a48fb0607626bbadf"><gtr:id>8ef586f0ee752b9a48fb0607626bbadf</gtr:id><gtr:otherNames>Li K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>3110222B077</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>65FCB4F4-5D6F-4337-92FA-DBF2C92E19F3</gtr:id><gtr:title>Targeting of mannan-binding lectin-associated serine protease-2 confers protection from myocardial and gastrointestinal ischemia/reperfusion injury.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c6856aa066a730da9d045725584a65ea"><gtr:id>c6856aa066a730da9d045725584a65ea</gtr:id><gtr:otherNames>Schwaeble WJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>D261D96A_BD261D96A_B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B0BF4AF3-1C23-4D7B-B5DA-0BB8BB1130EC</gtr:id><gtr:title>Genomics in human renal transplantation.</gtr:title><gtr:parentPublicationTitle>Current opinion in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9a99254fd6d34c2aa17b4bb1f18d72b7"><gtr:id>9a99254fd6d34c2aa17b4bb1f18d72b7</gtr:id><gtr:otherNames>Vaughan R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0952-7915</gtr:issn><gtr:outcomeId>KH5ZwD5gFDU</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CF7E4EDF-807E-40BE-9969-07F663D63C51</gtr:id><gtr:title>Recombinant complement receptor 2 radiolabeled with [99mTc(CO)3]+: a potential new radiopharmaceutical for imaging activated complement.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a9e46450847bc63d817ad16c0a2311cb"><gtr:id>a9e46450847bc63d817ad16c0a2311cb</gtr:id><gtr:otherNames>Badar A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>X5ey8A12qcv</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7B678287-2C2E-4D50-BC14-502807CAFD5D</gtr:id><gtr:title>The role of anaphylatoxins C3a and C5a in regulating innate and adaptive immune responses.</gtr:title><gtr:parentPublicationTitle>Inflammation &amp; allergy drug targets</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/92e71281a7b654e3b4d9e3098f4ece2e"><gtr:id>92e71281a7b654e3b4d9e3098f4ece2e</gtr:id><gtr:otherNames>Peng Q</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1871-5281</gtr:issn><gtr:outcomeId>443866F5027</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D974016D-D01E-4DA3-A984-0A4734169C62</gtr:id><gtr:title>SPECT/CT lymphoscintigraphy of heterotopic cardiac grafts reveals novel sites of lymphatic drainage and T cell priming.</gtr:title><gtr:parentPublicationTitle>American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f9bfb181c1926dd7c072e90ee249126c"><gtr:id>f9bfb181c1926dd7c072e90ee249126c</gtr:id><gtr:otherNames>Brown K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1600-6135</gtr:issn><gtr:outcomeId>hzbEPUmmYRg</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0600892</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>2EEE0958-6BE1-4D16-B86B-5D954CD37219</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Renal and Urogenital</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>67</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>78E3B265-B307-4D06-9AB7-1F69471E721F</gtr:id><gtr:percentage>33</gtr:percentage><gtr:text>5.4  Surgery</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>